Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Denning

Showing results (331-340 of 466) with videos related to

Pageof 47
Sort By:
Mycoses|September 6, 2018
The role of medical mycology societies in combating invasive fungal infections in low- and middle-income countries: A Nigerian modelRita O Oladele, Iriagbonse I Osaigbovo, Olusola O Ayanlowo, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2006
Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasisWilliam W Hope, George L Drusano, Caroline B Moore, et al.
Antimicrobial Agents and Chemotherapy|September 7, 2006
Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effectWilliam W Hope, Peter A Warn, Andrew Sharp, et al.
Therapeutic Advances in Urology|December 22, 2023
Isolated renal and urinary tract aspergillosis: a systematic reviewFelix Bongomin, Bethan Morgan, Bassey E Ekeng, et al.
The Journal of Antimicrobial Chemotherapy|August 31, 2020
Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimensLilyann Novak-Frazer, Samuel P Anees-Hill, Darin Hassan, et al.
The Lancet. Infectious Diseases|September 1, 2022
The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysisRadha Rajasingham, Nelesh P Govender, Alexander Jordan, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2007
Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosingWilliam W Hope, Peter A Warn, Andrew Sharp, et al.
BMC Public Health|October 29, 2021
Risk factors associated with respiratory infectious disease-related presenteeism: a rapid reviewSarah Daniels, Hua Wei, Yang Han, et al.
Mycopathologia|March 3, 2012
The performance of real-time PCR, galactomannan, and fungal culture in the diagnosis of invasive aspergillosis in ventilated patients with chronic obstructive pulmonary disease (COPD)Valério R Aquino, Fabiano Nagel, Huander F Andreolla, et al.
Plos One|May 5, 2023
Modelling the impact of non-pharmaceutical interventions on workplace transmission of SARS-CoV-2 in the home-delivery sectorCarl A Whitfield, Martie van Tongeren, Yang Han, et al.
Pageof 47

Showing results (331-340 of 466) with videos related to

Sort By:
Pageof 47
Mycoses|September 6, 2018
The role of medical mycology societies in combating invasive fungal infections in low- and middle-income countries: A Nigerian modelRita O Oladele, Iriagbonse I Osaigbovo, Olusola O Ayanlowo, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2006
Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasisWilliam W Hope, George L Drusano, Caroline B Moore, et al.
Antimicrobial Agents and Chemotherapy|September 7, 2006
Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effectWilliam W Hope, Peter A Warn, Andrew Sharp, et al.
Therapeutic Advances in Urology|December 22, 2023
Isolated renal and urinary tract aspergillosis: a systematic reviewFelix Bongomin, Bethan Morgan, Bassey E Ekeng, et al.
The Journal of Antimicrobial Chemotherapy|August 31, 2020
Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimensLilyann Novak-Frazer, Samuel P Anees-Hill, Darin Hassan, et al.
The Lancet. Infectious Diseases|September 1, 2022
The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysisRadha Rajasingham, Nelesh P Govender, Alexander Jordan, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2007
Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosingWilliam W Hope, Peter A Warn, Andrew Sharp, et al.
BMC Public Health|October 29, 2021
Risk factors associated with respiratory infectious disease-related presenteeism: a rapid reviewSarah Daniels, Hua Wei, Yang Han, et al.
Mycopathologia|March 3, 2012
The performance of real-time PCR, galactomannan, and fungal culture in the diagnosis of invasive aspergillosis in ventilated patients with chronic obstructive pulmonary disease (COPD)Valério R Aquino, Fabiano Nagel, Huander F Andreolla, et al.
Plos One|May 5, 2023
Modelling the impact of non-pharmaceutical interventions on workplace transmission of SARS-CoV-2 in the home-delivery sectorCarl A Whitfield, Martie van Tongeren, Yang Han, et al.
Pageof 47